GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

DNDI-6510   Click here for help

GtoPdb Ligand ID: 13989

Synonyms: (S)-x38 DNDI-6510 | DNDI6510 | MAT-POS-e48723dc-2 [1] | Mpro-P3038 [1]
PDB Ligand
Compound class: Synthetic organic
Comment: DNDI-6510 is a non-covalent SARS-CoV-2 3C-like (main) protease (Mpro) inhibitor [2]. It was developed though leads produced via the open science COVID Moonshot project. Development was discontinued when it was discovered that DNDI-6510 promoted pregnane X receptor (PXR)-linked auto-induction of drug metabolism in mouse and rat in vivo, and in human hepatocyte cell lines.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 82.08
Molecular weight 474.94
XLogP 0.2
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC(=O)C1(CC1)N2C[C@]3(CCN(C4=CN=CC5=C4C=CC=C5)C3=O)C6=CC(=CC=C6C2=O)Cl
Isomeric SMILES CNC(=O)C1(CC1)N2C[C@]3(CCN(C3=O)C4=CN=CC5=CC=CC=C54)C6=C(C2=O)C=CC(=C6)Cl
InChI InChI=1S/C26H23ClN4O3/c1-28-23(33)26(8-9-26)31-15-25(20-12-17(27)6-7-19(20)22(31)32)10-11-30(24(25)34)21-14-29-13-16-4-2-3-5-18(16)21/h2-7,12-14H,8-11,15H2,1H3,(H,28,33)/t25-/m1/s1
InChI Key FLEUPKADUSMVNQ-RUZDIDTESA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
DNDI-6510 exhibits potent antiviral activity against SARS-CoV, SARS-CoV-2 and known SARS-CoV-2 variants of concern [2]. It is essentially inactive against the Mpro enzymes from the OC34, HKU1 MERS, 229E, and NL63 human coronaviruses.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CoV 3C-like (main) protease SARS-CoV-2 Inhibitor Inhibition 7.1 pEC50 - 2
pEC50 7.1 (EC50 7.7x10-8 M) [2]
Description: Antiviral efficacy against SARS-CoV-2 in a cellular A549 assay.
CoV 3C-like (main) protease SARS-CoV-2 Inhibitor Inhibition 6.8 pIC50 - 2
pIC50 6.8 (IC50 1.71x10-7 M) [2]
Description: Inhibition of SARS-CoV-2 MPro proteolytic activity determined in a FRET assay
CoV 3C-like (main) protease SARS-CoV Inhibitor Inhibition 6.5 pIC50 - 2
pIC50 6.5 (IC50 3.23x10-7 M) [2]
Description: Inhibition of SARS-CoV MPro proteolytic activity determined in a FRET assay